Assessing State, Federal Health Policies for Opioid Use Disorder Treatment During Pandemic

JAMA Health Forum

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, NOVEMBER 19, 2021

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2021.3833?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=111921

About JAMA Heath Forum: JAMA Health Forum has transitioned from an information channel to an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.

 

What The Study Did: This analysis of policy changes implemented during the COVID-19 pandemic found that federal and state governments have taken important steps to ensure the availability of treatment for opioid use disorder, but few states are comprehensive in their approach.

Authors: Rosalie Liccardo Pacula, Ph.D., of the University of Southern California in Los Angeles, is the corresponding author.

 

(doi:10.1001/jamahealthforum.2021.3833)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.